Investigation of Potent Antifungal Metabolites from Marine Streptomyces bacillaris STR2 (MK045300) from Western Algeria

Fungal infections significantly threaten public health, and many strains are resistant to antifungal drugs. Marine Actinobacteria have been identified as the generators of powerful bioactive compounds with antifungal activity and can be used to address this issue. In this context, strains of Actinomycetes were isolated from the marine area of Rachgoun Island, located in western Algeria. The isolates were phenotypically and genetically characterized. The most potent antifungal isolate was selected, and its crude extract was purified and characterized by the GC/MS method. The results revealed that the STR2 strain showed the strongest activity against at least one target fungal species tested on a panel of fungal pathogens, including Candida albicans, Aspergillus fumigatus, Aspergillus niger, and Fusarium oxysporum. The molecular assignment of the STR2 strain based on the 16S rRNA gene positioned this isolate as a Streptomyces bacillaris species. The presence of safranal (2,3-dihydro-2,2,6-trimethylbenzaldehyde) in the crude chloroform extract of Streptomyces bacillaris STR2 strain was discovered for the first time in bacteria using chromatographic analysis of its TLC fractions. Moreover, certain molecules of biotechnological interest, such as phenols, 1,3-dioxolane, and phthalate derivatives, were also identified. This study highlights the potential of marine actinomycetes to produce structurally unique natural compounds with antifungal activity.